These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32031202)

  • 21. Limonin ameliorates cardiovascular dysfunction and remodeling in hypertensive rats.
    Iampanichakul M; Potue P; Rattanakanokchai S; Maneesai P; Khamseekaew J; Settheetham-Ishida W; Pakdeechote P
    Life Sci; 2023 Aug; 327():121834. PubMed ID: 37290669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hesperidin inhibits L-NAME-induced vascular and renal alterations in rats by suppressing the renin-angiotensin system, transforming growth factor-β1, and oxidative stress.
    Bunbupha S; Apaijit K; Potue P; Maneesai P; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2021 Mar; 48(3):412-421. PubMed ID: 33185907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
    Ji W; Liu S; Dai J; Yang T; Jiang X; Duan X; Wu Y
    Chin Med J (Engl); 2014; 127(21):3751-7. PubMed ID: 25382331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barnidipine ameliorates the vascular and renal injury in L-NAME-induced hypertensive rats.
    Alp Yildirim FI; Eker Kizilay D; Ergin B; Balci Ekmekçi Ö; Topal G; Kucur M; Demirci Tansel C; Uydeş Doğan BS
    Eur J Pharmacol; 2015 Oct; 764():433-442. PubMed ID: 26187312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
    J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
    Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX; Pan SN; Meng RS; Peng CQ; Xiong ZJ; Chen BL; Chen GQ; Yao FJ; Chen YL; Ma YD; Dong YG
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):55-62. PubMed ID: 21083698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y; Ono H; Zhou X; Frohlich ED
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of endogenous nitric oxide in angiotensin II-induced activation of vascular mitogen-activated protein kinases.
    Zhang GX; Nagai Y; Nakagawa T; Miyanaka H; Fujisawa Y; Nishiyama A; Izuishi K; Ohmori K; Kimura S
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2403-8. PubMed ID: 17616751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkia speciosa empty pod prevents hypertension and cardiac damage in rats given N(G)-nitro-l-arginine methyl ester.
    Kamisah Y; Zuhair JSF; Juliana AH; Jaarin K
    Biomed Pharmacother; 2017 Dec; 96():291-298. PubMed ID: 28992471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation.
    Seo J; Lee HS; Ryoo S; Seo JH; Min BS; Lee JH
    Eur J Pharmacol; 2011 Dec; 673(1-3):56-64. PubMed ID: 22040922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tangeretin ameliorates renal failure via regulating oxidative stress, NF-κB-TNF-α/iNOS signalling and improves memory and cognitive deficits in 5/6 nephrectomized rats.
    Wu J; Zhao YM; Deng ZK
    Inflammopharmacology; 2018 Feb; 26(1):119-132. PubMed ID: 28871498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.